---
title: "Kobo Biotech Ltd (531541) — Share Price, Financials & Analysis"
symbol: "531541"
company: "Kobo Biotech Ltd"
canonical: "https://tapetide.com/stocks/531541"
isin: "INE881A01015"
nse_symbol: "AVONLIFESCIENCESLTD"
bse_code: "531541"
sector: "Chemicals"
industry: "Commodity Chemicals"
market_cap_cr: 11.3
generated_at: "2026-09-13T19:39:52.631Z"
---

# Kobo Biotech Ltd (531541)

Canonical page: https://tapetide.com/stocks/531541

## Company

- **NSE Symbol:** AVONLIFESCIENCESLTD
- **BSE Code:** 531541
- **ISIN:** INE881A01015
- **Sector:** Chemicals
- **Industry:** Commodity Chemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** avonlifesciences.com

## About

Incorporated in 1993, Kobo Biotech Ltd is in the pharmaceutical business[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:34:28.025924Z.

- **Market Cap:** ₹11.3 Cr
- **Classification:** Microcap
- **P/E (reported):** -2.2
- **Book Value:** ₹-57.98
- **Price to Book:** -0.08
- **Dividend Yield:** 0%
- **ROE:** -65.6%
- **ROCE:** -7.79%
- **Debt to Equity:** 3.38
- **Revenue (yearly):** ₹103.4 Cr
- **Net Income:** ₹-34.8 Cr
- **EBITDA:** ₹-0.7 Cr
- **52-Week High:** ₹9.99
- **52-Week Low:** ₹1.99
- **RSI (14):** 28.34

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 292.98% | — | — |
| ebitda margin growth | 0% | — | — | — |
| net income growth | 0% | -6% | 18% | 12% |
| revenue growth | 0% | — | — | — |
| roce | 5.56% | — | — | — |
| roe | 5.56% | — | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.7 | 0.3 | 9.24 | 0.34 | 0.21 | 0.17 | 0.79 | 0.23 | 0.2 | 0.2 | 0.25 | 0.34 |
| Operating Profit | -0.7 | -0.3 | -9.24 | -0.34 | -0.21 | -0.17 | -0.79 | -0.23 | -0.2 | -0.2 | -0.25 | -0.34 |
| Other Income | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.02 |
| Interest | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1.03 | 1.04 | 1.18 | 1.15 | 0.89 | 1.03 | 1 | 1.01 | 1.02 | 1.03 | 1.01 | 1.01 |
| Profit before tax | -1.86 | -1.34 | -10.42 | -1.47 | -1.1 | -1.2 | -1.79 | -1.22 | -1.22 | -1.23 | -1.26 | -1.33 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1.86 | -1.35 | -10.42 | -1.47 | -1.1 | -1.19 | -1.79 | -1.23 | -1.22 | -1.23 | -1.26 | -1.33 |
| EPS in Rs | -0.78 | -0.57 | -4.37 | -0.62 | -0.46 | -0.5 | -0.75 | -0.52 | -0.51 | -0.52 | -0.53 | -0.56 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 32.54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 27.74 | 4.05 | 3.02 | 1.72 | 0.69 | 2.79 | 10.51 | 1.5 | 0.88 | 1.24 |
| Operating Profit | 4.8 | -4.05 | -3.02 | -1.72 | -0.69 | -2.79 | -10.51 | -1.5 | -0.88 | -1.24 |
| OPM % | 14.75 | — | — | — | — | — | — | — | — | — |
| Other Income | 0.42 | 6 | 0.04 | -2.15 | 0.03 | 0.04 | 0.02 | 0.02 | 0.02 | 0.08 |
| Interest | 14.37 | 14.41 | 14.5 | 14.44 | 14.47 | 10.84 | 0.13 | 0 | 0 | 0 |
| Depreciation | 7.31 | 6.78 | 6.44 | 6.15 | 5.88 | 5.64 | 4.61 | 4.07 | 4.07 | 4.07 |
| Profit before tax | -16.46 | -19.24 | -23.92 | -24.46 | -21.01 | -19.23 | -15.23 | -5.55 | -4.93 | -5.23 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -16.46 | -19.24 | -23.92 | -24.46 | -21.01 | -19.23 | -15.23 | -5.55 | -4.93 | -5.23 |
| EPS in Rs | -6.94 | -8.08 | -10.04 | -10.27 | -8.82 | -8.07 | -6.39 | -2.33 | -2.07 | -2.2 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 23.73 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 |
| Reserves | -17.3 | -42.41 | -66.33 | -90.79 | -111.8 | -131.03 | -146.25 | -151.81 | -156.74 | -161.97 |
| Borrowings | 152.68 | 207.6 | 221.96 | 236.36 | 250.76 | 260.53 | 140.71 | 139.84 | 139.69 | 139.69 |
| Other Liabilities | 101.36 | 63.2 | 66.48 | 70.04 | 73.54 | 77.26 | 60.89 | 63.47 | 64.62 | 70.04 |
| Total Liabilities | 260.47 | 252.22 | 245.94 | 239.44 | 236.33 | 230.59 | 79.18 | 75.33 | 71.4 | 71.59 |
| Fixed Assets | 87.79 | 81.01 | 74.56 | 68.42 | 62.54 | 56.91 | 41.66 | 37.59 | 33.52 | 29.44 |
| CWIP | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 0 | 0 | 0 | 0 |
| Investments | 12.19 | 12.19 | 12.19 | 12.19 | 12.19 | 12.19 | 0 | 0 | 0 | 0 |
| Other Assets | 158.24 | 156.77 | 156.94 | 156.58 | 159.35 | 159.24 | 37.52 | 37.74 | 37.88 | 42.15 |
| Total Assets | 260.47 | 252.22 | 245.94 | 239.44 | 236.33 | 230.59 | 79.18 | 75.33 | 71.4 | 71.59 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 5.62 | 32.3 | 31.47 | 20.95 | 14.48 | 2.51 | 93.76 | 0.87 | 0.2 | 4.18 |
| Cash from Investing Activity | 0 | 0 | 0 | 0 | 0 | 0 | 25.09 | 0 | 0 | 0 |
| Cash from Financing Activity | -5.27 | -32.76 | -31.47 | -20.95 | -14.47 | -1.08 | -120.28 | -0.87 | -0.15 | 0 |
| Net Cash Flow | 0.35 | -0.46 | 0 | 0 | 0 | 1.43 | -1.43 | 0 | 0.05 | 4.18 |
| Free Cash Flow | 5.62 | 32.3 | 31.47 | 20.95 | 14.48 | 2.51 | 106.65 | 0.87 | 0.2 | 4.18 |
| CFO/OP | 117 | -798 | -1042 | -1218 | -2099 | -90 | -892 | -58 | -23 | -337 |

### Ratios

| Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 1006.5 | — | — | — | — | — | — | — | — | — |
| Inventory Days | 1038.63 | — | — | — | — | — | — | — | — | — |
| Days Payable | 1092.57 | — | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 952.56 | — | — | — | — | — | — | — | — | — |
| Working Capital Days | -251.48 | — | — | — | — | — | — | — | — | — |
| ROCE % | -1.33 | -2.77 | -5.11 | -4.49 | -3.94 | -5.31 | -17.6 | -36.82 | -52.9 | -125.57 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.66% | 0.66% | 0.66% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 47.86% | 47.97% | 48.27% | 48.26% | 48.49% | 48.24% | 48.07% | 47.98% | 47.95% | 47.9% | 47.77% | 45.72% |
| Others | 6.53% | 6.42% | 6.12% | 6.79% | 6.56% | 6.81% | 6.98% | 7.08% | 7.1% | 7.15% | 7.28% | 9.33% |
| No. of Shareholders | 6478 | 6530 | 6767 | 6788 | 6916 | 7542 | 7873 | 7929 | 7947 | 7970 | 7977 | 7734 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 8 / 1 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 5.05 | Sell |
| EMA (10) | 4.98 | Sell |
| SMA (20) | 5.07 | Sell |
| EMA (20) | 5.31 | Sell |
| SMA (50) | 6.93 | Sell |
| EMA (50) | 5.93 | Sell |
| SMA (100) | 5.73 | Sell |
| EMA (100) | 5.61 | Sell |
| SMA (200) | 4.15 | Buy |
| EMA (200) | 4.75 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 27.17 | Buy |
| MACD (12,26,9) | -0.48 | Buy |
| Stochastic (14,3,3) | 0 | Buy |
| ADX (14) | 40.84 | Buy |
| Williams %R (14) | -100 | Buy |
| ATR (14) | 0.18 | High Volatility |
| ROC (12) | -17.47 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 13.66 | Buy |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-07-24 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2be03a24-6995-44ab-b062-f2dde0d25a56.pdf) |
| 2026-07-24 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=040f615f-acc2-4521-a451-b2095bb50b4e.pdf) |
| 2026-07-24 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b24a2b6-ff31-4b2c-99a0-5d857f7ef211.pdf) |
| 2026-07-24 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f9c8799-dd5b-44f6-92e2-901be875f3ef.pdf) |
| 2026-07-17 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7038a80-4400-42e0-8d28-2a519491b562.pdf) |
| 2026-07-16 | [Update On Implementation Of Approved Resolution Plan Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=059ad359-387f-455f-866c-f76f5ebc75fe.pdf) |
| 2026-06-29 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=212faeaf-8579-473f-9e0b-155f389480a7.pdf) |
| 2026-06-29 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1b1e728-d2e1-4722-a7f6-c11a2b6d9d65.pdf) |
| 2026-06-26 | [31St Annual General Meeting Of The Memberswill Be Held On Friday July 24 2026 At 10.00 A.M. (IST) Through Video Conferencing/ Other Audio Visual Means (VC/OAVM)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b32b9447-a1e5-41ff-81e7-dff13fd17892.pdf) |
| 2026-06-26 | [32St Annual General Meeting Of The Members Will Be Held On Friday July 24 2026 At 11.00 A.M. (IST) Through Video Conferencing/ Other Audio Visual Means (VC/OAVM)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0382b29d-56db-4326-a8a8-27a86b87f42e.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8h - NCLT approved Beaufond Industries' resolution plan for Kobo Biotech on 11 May 2026, with 100% CoC vote. | [Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal 8h - NCLT approved Beaufond Industries' resolution plan for Kobo Biotech on 11 May 2026, with 100% CoC vote.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/10c50aa7-a692-48a7-96fd-b4423385b92b.pdf) |
| 4 Feb - RTA certificate confirming dematerialisation compliance under Reg 74(5) for quarter ended 31 December 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 4 Feb - RTA certificate confirming dematerialisation compliance under Reg 74(5) for quarter ended 31 December 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1f60d54a-9e70-48bf-9608-4920a609330e.pdf) |
| 15 Apr - Compliance certificate under Reg. 74(5) of SEBI (DP) for the quarter ended 31.03.2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 15 Apr - Compliance certificate under Reg. 74(5) of SEBI (DP) for the quarter ended 31.03.2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/140082d3-edf5-48e2-bb25-f4cdbfffb410.pdf) |
| 15 Apr - Company confirmed it is not a Large Corporate as of 31 March 2026. | [Intimation Regarding Non-Applicability Of Large Entity Disclosure 15 Apr - Company confirmed it is not a Large Corporate as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8c20bdbe-f60f-43ff-8b8f-4c11fc134e7f.pdf) |
| 11 Feb - RTA certificate confirming compliance under SEBI Regulation 74(5) for quarter ended September 30, 2024. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Feb - RTA certificate confirming compliance under SEBI Regulation 74(5) for quarter ended September 30, 2024.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cc34b8d1-0985-4c7f-b377-bb8daba631ba.pdf) |
| 11 Feb - RTA certificate confirming compliance under SEBI Reg 74(5) for quarter ended 31-Dec-2024. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Feb - RTA certificate confirming compliance under SEBI Reg 74(5) for quarter ended 31-Dec-2024.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/138f3bdc-3262-4bb1-8132-1c1c8888159f.pdf) |
| 11 Feb - Certificate under SEBI Regulation 74(5) for quarter ended 31 March 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Feb - Certificate under SEBI Regulation 74(5) for quarter ended 31 March 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bbf97658-599b-49c3-bbae-b087e5537652.pdf) |
| — | [Closure of Trading Window 30 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cfe1df1f-a7da-49fd-b235-f0827fbb3296.pdf) |
| — | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a765829d-095a-4ef1-8df9-b2d4cdb74858.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_IVRCLAH_2010_2011_11102011062221.zip) |
| from nse | [Financial Year 2010 from nse](https://archives.nseindia.com/annual_reports/AR_IVRCLAH_2009_2010_30082010120000.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f1b1e728-d2e1-4722-a7f6-c11a2b6d9d65.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/212faeaf-8579-473f-9e0b-155f389480a7.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5491b8e7-3248-4c3f-9f0c-70aaa9c1fdc4.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531541/76804531541.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/531541/72710531541.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/531541/67979531541.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/531541/5315410319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/531541/5315410318.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2024-08-14 | [Unaudited Financial Results For The Quarter Ended 30Th June, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=738dfde5-74c2-4c46-8097-22e6fe605519.pdf) |
| 2024-05-30 | [Audited Financial Results For The Quarter And Year Ended 31St March, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4befa81-638f-4e3d-8442-ed8fd8f88f6e.pdf) |
| 2024-02-14 | [Financial Result For The Quarter And Nine Months Ended 31St December, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33418a55-1b38-48a5-bede-58ed061bce78.pdf) |
| 2023-11-10 | [Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8adac86-b496-4fdd-9145-467ed12710df.pdf) |
| 2023-08-11 | [Unaudited Financial Results For The Quarter Ended 30Th June, 2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c0ed6fc-3d3a-4ac5-81ea-474cbcfe3d78.pdf) |
| 2023-05-30 | [Financial Results For 31St March, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a011a107-c18a-459f-90d0-4c1e3aa05423.pdf) |
| 2023-02-13 | [Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2022.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff390c31-ca46-47e3-8061-3c744802bb33.pdf) |
| 2022-11-29 | [Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2022 Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''Listing Regulations'')](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca4112d8-94fc-4098-85c3-c681620f034b.pdf) |
| 2022-11-14 | [Board Meeting Outcome for OUTCOME OF THE BOARD MEETING: Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8beadb54-2cbb-4d65-8766-f9464de15317.pdf) |
| 2022-08-11 | [OUTCOME OF THE BOARD MEETING: Unaudited Financial Results For The Quarter Ended 30Th June, 2022.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d51c013-5148-4671-80c1-5851bb61d1d1.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:39:52.631Z.